Minnesota Inclusive LTSS for LGBTQ Seniors (MILLS)

April 27, 2026 updated by: University of Minnesota

Training the Long-Term Services and Supports Dementia Care Workforce in Provision of Care to Sexual and Gender Minority Residents

This study is designed to help improve the care of sexual and gender minority (SGM) with Alzheimer's Disease and Alzheimer's Disease Related Dementia (AD/ADRD) in long-term services and supports (LTSS) by training the state's LTSS workforce in SGM culturally responsive care. The randomized controlled trial will rigorously test the effects of an in person versus an online training program on improving SGM culturally responsive care with a waitlist control.

Study Overview

Detailed Description

The study involves conducting a 3-arm, stratified (management/staff), group (agency) randomized controlled trial (RCT) of the in-person vs. online intervention vs. waitlist control on organizational factors (i.e., environment and policy) and on staff knowledge, attitudes, and skills.

Study Type

Interventional

Enrollment (Actual)

761

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Minnesota
      • Minneapolis, Minnesota, United States, 55455
        • University of Minnesota

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • licensure in Minnesota to provide nursing and/or as a housing with services establishment
  • Willingness to undertake a policy and environment review at baseline and 6 months later
  • having at least 5 managers/ supervisors and 5 staff.

Exclusion Criteria:

  • Participants who cannot speak and read English

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Training to Serve (TTS) in person training
Participants are provided access to the pretest one week before the training. On the day of training, when the trainers arrive, participants have a final opportunity to complete the baseline survey before the intervention. Tablets will be available to complete pre- and post- surveys. The training for management takes 3-4 hours, and for staff, one hour. For consistency and feasibility, both trainings are conducted by the same trainers at the same visit. Immediately after the intervention, participants complete the post-intervention seminar evaluation assessing knowledge and attitudes/comfort in serving SGM clients.
Participants receive in person training.
Experimental: Training to Serve online training (eTTS)
Participants are provided a unique identifier to access the online website. The opening page welcomes them to the study, then directs them to the chunked consent materials and baseline survey. As soon as they have completed this, they receive access to the intervention, which for management is expected to take 1-2 hours and for staff, 30-45 minutes (i.e., the online equivalent of 3-4 and 1 hour, respectively). After completion of the required modules, participants receive access to the optional modules as well as the posttest survey to evaluate the training. Once the post-test is complete, they are thanked for their involvement and informed they will receive an e-mail to access a follow-up survey in six months' time.
Participants receive online training.
No Intervention: Waitlist control
Participants complete the baseline survey, then they receive a note thanking them for completing all activities and informing them the intervention will be available in 6 months' time.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Environment change
Time Frame: baseline and 6-months follow up
Access to sexual and gender minority (SGM) providers, gender neutral intake forms
baseline and 6-months follow up
Skills assessment
Time Frame: Baseline
Ability to conduct 7 skills key to providing competent care to SGM
Baseline
Skills assessment
Time Frame: Immediately post-intervention
Ability to conduct 7 skills key to providing competent care to SGM
Immediately post-intervention
Competence in SGM Care
Time Frame: 6 months after intervention
Competent scale when it comes to providing care to SGM
6 months after intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
SGM with AD/ADRD referenced explicitly in policies
Time Frame: Baseline
Human Resources policies and intake forms
Baseline
SGM with AD/ADRD referenced explicitly in policies
Time Frame: 6 months post-intervention
HR policies and intake forms
6 months post-intervention
SGM knowledge
Time Frame: Baseline
10-item review of key content in training
Baseline
SGM knowledge
Time Frame: immediately post-intervention
10-item review of key content in training
immediately post-intervention
SGM knowledge
Time Frame: 6 months post-intervention
10-item review of key content in training
6 months post-intervention
SGM attitudes
Time Frame: Baseline
Homonegativity scale
Baseline
SGM attitudes
Time Frame: immediately post-intervention
Homonegativity scale
immediately post-intervention
SGM attitudes
Time Frame: 6 months post-intervention
Homonegativity scale
6 months post-intervention
Health care empathy
Time Frame: Baseline
Jefferson Physician Empathy student version
Baseline
Health care empathy
Time Frame: immediately post-intervention
Jefferson Physician Empathy student version
immediately post-intervention
Health care empathy
Time Frame: 6 months post-intervention
Jefferson Physician Empathy student version
6 months post-intervention

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Discrimination experience at work
Time Frame: Baseline
Adapted everyday discrimination scale
Baseline
Discrimination experience at work
Time Frame: immediately post-intervention
Adapted everyday discrimination scale
immediately post-intervention
Discrimination experience at work
Time Frame: 6 months post-intervention
Adapted everyday discrimination scale
6 months post-intervention
Social desirability at work
Time Frame: Baseline
Marlowe Crowne Social desirability scale
Baseline
Social desirability at work
Time Frame: immediately post-intervention
Marlowe Crowne Social desirability scale
immediately post-intervention
Social desirability at work
Time Frame: 6 months post-intervention
Marlowe Crowne Social desirability scale
6 months post-intervention
Sexual and Religious Identification
Time Frame: Baseline
Duke Religiosity Index
Baseline
Sexual and Religious Identification
Time Frame: 6 months follow-up post-intervention
Duke Religiosity Index
6 months follow-up post-intervention
Agency demographics
Time Frame: Baseline
Agency type, size and staff
Baseline
SGM estimate
Time Frame: Baseline and 6 month follow up.
Number of SGM staff
Baseline and 6 month follow up.
SGM estimate
Time Frame: 6 months follow up post-intervention
Number of SGM staff
6 months follow up post-intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Simon Rosser, PhD,MPH, University of Minnesota
  • Principal Investigator: Tetyanna Shippee, PhD, University of Minnesota

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 31, 2024

Primary Completion (Actual)

December 12, 2025

Study Completion (Actual)

December 12, 2025

Study Registration Dates

First Submitted

July 22, 2022

First Submitted That Met QC Criteria

September 1, 2022

First Posted (Actual)

September 7, 2022

Study Record Updates

Last Update Posted (Actual)

April 29, 2026

Last Update Submitted That Met QC Criteria

April 27, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe